Commentary on: Abiomed Impella® 2.5 patient transport: lessons learned

Griffith, Kevin
November 2010
Perfusion;Nov2010, Vol. 25 Issue 6, p387
Academic Journal
The article discusses the Impella® 2.5, a partial flow device for the heart which was presented at the 30th Annual Seminar of the American Academy of Cardiovascular Perfusion. It states that Impella® is employed in cardiac catheterization laboratories which lack backup care for the patients. It says that the Impella® did not feature excessive hemolysis. It adds that Impella® has been used as a left ventricular assist instrument without malposition difficulties.


Related Articles

  • Abiomed Impella ® 2.5 patient transport: lessons learned. Griffith, Kevin E.; Jenkins, Eric // Perfusion;Nov2010, Vol. 25 Issue 6, p381 

    The Abiomed Impella ® 2.5 is a micro-axial flow, catheter-based left ventricular assist system (LVAS). Designed for percutaneous insertion into the femoral artery and positioned across the aortic valve, the Impella® is capable of pumping 2.5 liters of blood per minute from the...

  • Heart device cuts A&E admissions 40%. Robinson, Stephen // GP: General Practitioner;2/18/2011, p13 

    The article offers information on the impact of heart devices in declining the cases of heart failure. It states that according to a research remote monitoring of patients with heart failure could cut emergency hospital admissions for the condition by 40 percent. It mentions that 83 heart...

  • Regionalized approach to emergency medical services training for the care of patients with mechanical assist devices. Van de Bussche, Todd J.; Edwards, Lori G.; Elliott, Tonya; Harton, Suzie; Rivard, Dennis; Wolfe, Jr., Allen C. // Progress in Transplantation;Jun2010, Vol. 20 Issue 2, p129 

    Advances in mechanical circulatory assist device technology have allowed dozens of patients with different types of devices to live in any community in the United States. Some of the newer devices pump blood continuously, resulting in patients without pulses. The mechanical circulatory assist...

  • Are supplies all there and in working order?  // ED Nursing;Sep2010, Vol. 13 Issue 11, p129 

    The article focuses on the transportation of an unstable patient with low blood pressure and heart rate. It states that when transporting a patient, the medical staff must have the patient's chart with therapeutic support order such as full advanced cardiac life support (ACLS), a ventilator with...

  • Epidemic of Hemolysis Highlights Need for Coordinated Investigation. Duffy, R.; Tomashek, K.; Spangenberg, M. // Kidney;Nov/Dec2000, Vol. 9 Issue 6, p255 

    Focuses on a study which reported the results of an investigation conducted during an epidemic of hemolysis among hemodialysis patients. Methodology; Results; Conclusion.

  • New applications of cardiovascular magnetic resonance to guide cardiac resynchronization therapy. Petryka, Joanna; Oręziak, Artur; Przybylski, Andrzej; Miśko, Jolanta // Advances in Interventional Cardiology;2012, Vol. 8 Issue 3, p234 

    The article discusses the clinical usefulness and new applications of cardiovascular magnetic resonance (CMR) in cardiac resynchronization therapy (CRT). It offers information on the growing role of right ventricular function and scar homogeneity. It concludes that in order to maximize the...

  • Avoid a terrible outcome with ED patient transport.  // ED Nursing;Sep2010, Vol. 13 Issue 11, p129 

    The article offers tips on how to deal with unexpected circumstances while transferring an uncontrolled seizure patient from the emergency department (ED). It mentions that the area receiving the patient must be notified of the timeline of the transfer and must be equipped with the necessary...

  • Reduction in Hemolyzed Samples with New Heel Lancet. Eudy, Margo; Melton, Angela // Clinical Leadership & Management Review;Nov/Dec2009, Vol. 23 Issue 3, pE1 

    The article offers information on the comparison of the NeatNick Heel Lancet and the Tenderfoot heel lancet for reducing hemolyzed samples. It notes that the new NeatNick Heel Lancet provides better blood flow due to blade speed, blade quality and incision quality. The study compared the...

  • Biotronik gets CE mark for remote patient monitoring technology.  // Medical Device Daily;10/19/2009, Vol. 13 Issue 201, p1 

    The article reports on the Communauté Européenne (CE) mark received by Biotronik, a manufacturer of implantable cardiac devices, for its remote patient monitoring technology called Biotronik Home Monitoring. The remote patient monitoring device is for patients with implantable cardiac...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics